JACOBS LEVY EQUITY MANAGEMENT, INC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 884414
FLORHAM PARK, NJ
Position in BCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,561,630
+$1,516,024 QoQ
Shares Held
1,004,373
-2.6% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
4,273,026 | $4,871,249 |
All Filings in BCRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,561,630 | 1,004,373 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,045,606 | 1,031,488 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,811,814 | 370,463 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,418,060 | 381,480 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,076,442 | 276,859 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,863,418 | 247,795 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,793,106 | 367,514 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,570,721 | 739,599 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $793,084 | 156,119 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $577,418 | 96,397 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,328,569 | 470,137 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $8,136,289 | 1,155,723 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,966,420 | 2,034,343 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,853,856 | 1,468,106 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,248,227 | 416,526 | Shares | Sole | 2022-11-15 | |
| 2020-06-30 | $358,727 | 75,363 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $36,200 | 18,100 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||